MDMA Therapy Training Program Update: January 2022

The year 2021was a rewarding year for the MDMA Therapy Training Program, with a shift to entirely virtual trainings and an expanded capacity for cohort sizes. The training program enrolled a total of 800 trainees in their 2021 online cohorts.

Eight trainers facilitated the summer and fall virtual cohorts: Michael Mithoefer, M.D., Annie Mithoefer, B.S.N., Bruce Poulter, M.P.H., Marcela Ot’alora G., MA LPC, Brooke Balliett L.M.F.T., Phil Lister M.D., Ido Siemion, Ph.D., and Keren Tzarfaty, Ph.D., M.F.T. 

In 2021, the team rolled out and initiated our Health Equity Scholarship program, part of a larger commitment to increasing inclusion and equity in our programs. Over the course of this year, we were able to allocate and award $900,000 in Health Equity scholarships, amounting to a total of 231 scholarships. We are currently working to continue and expand this initiative for 2022 and beyond.

By awarding funds through the MAPS Health Equity Scholarship, the MDMA Therapy Training Program hopes to continue the efforts to create these outcomes in 2022: 

  • Create a more accessible training program to ensure that the network of MDMA-assisted therapy practitioners is vast and able to support diverse communities suffering from a spectrum of trauma 
  • Increase the number of MAPS-certified MDMA-assisted therapy practitioners who identify as Black, Indigenous, and people of color  
  • Train and learn from more therapy practitioners who live and work in historically marginalized communities
  • Foster connection and validate unique experiences of trauma in marginalized communities.  

Trainings for 2022
The 2022 training schedule is now available to view, including options for a blended (online/in person) training format and an entirely virtual training format.

Dates and locations for blended format cohorts are as follows:

  • April 3-8, North Carolina 
  • May 22-27, Colorado 
  • September 25-30, Colorado 

Additional dates and locations are still being finalized.

Virtual Cohorts (subject to change): 

  • Summer 2022 Virtual Cohort (May-August) 
  • Fall 2022 Virtual Cohort (September-December) 

Application Information  

The training application will remain open for future cohorts. Applications will be reviewed during an admissions and screening process for upcoming cohorts. Click here to apply.   

Previously submitted applications will remain on file and will be reviewed for upcoming training opportunities. 

For eligible applicants interested in applying for a MAPS Health Equity Scholarship, please find more information and the link to the application on our scholarship webpage.

Training Collaboration with Naropa University
The Naropa University Certificate in Psychedelic-Assisted Therapies is a ten-month contemplatively-based professional training program featuring a hybrid delivery of online and intensive retreat-based learning. This non-degree Certificate will provide post-graduate level training in essential aspects of Psychedelic-Assisted Therapy, trauma-informed care, and spiritual integration. In collaboration with the Multidisciplinary Association for Psychedelic Studies (MAPS), Naropa offers specialized training in the clinical use of MDMA in approved settings. Trainees will also gain foundational competencies in psilocybin therapies and ketamine-assisted therapy. Naropa began as a Buddhist-inspired university and now flourishes as an institution that brings together contemplative pedagogy and a commitment to socially-engaged activism. 

The certificate program formally opened applications on November 15, 2021, and the program will begin in March of 2022. Registration is now open and space is limited. Learn more and apply now!